ARTICLE | Company News
DuPont-Glaxo gene tool deal
February 17, 2000 8:00 AM UTC
Glaxo Wellcome (LSE:GLXO; GLX) obtained a license from DuPont Pharmaceuticals (Wilmington, Del.) for Cre-lox site-directed recombination technology to aid in deciphering gene function. ...